United States · FDA National Drug Code directory
Escitalopram
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-373_eee33c81-29aa-4666-af3b-fef9c3de6107
- Product NDC
- 65862-373
- Form
- TABLET, FILM COATED
- Composition / generic term
- Escitalopram Oxalate
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120911
- Source listing expiry
- 20271231
Source-listed ingredients
- ESCITALOPRAM OXALATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (65862-373-01) · 65862-373-01
- 500 TABLET, FILM COATED in 1 BOTTLE (65862-373-05) · 65862-373-05
- 10 BLISTER PACK in 1 CARTON (65862-373-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 65862-373-10
- 10000 TABLET, FILM COATED in 1 BOTTLE (65862-373-19) · 65862-373-19
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-373-30) · 65862-373-30
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-373-90) · 65862-373-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →